Kolon TissueGene
Phase 1Kolon Tissuegene develops cell and gene therapy for osteoarthritis diseases such as knees, spine and hip joints, and you can browse investment and company information on this site.
Founded
2000
Focus
BiologicsCell & Gene Therapy
About
Kolon Tissuegene develops cell and gene therapy for osteoarthritis diseases such as knees, spine and hip joints, and you can browse investment and company information on this site.
Funding History
2Total raised: $150M
Series B$100MKolon IndustriesJun 15, 2020
Series A$50MKolon IndustriesJun 15, 2018
Company Info
TypePrivate
Founded2000
LocationRockville, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile